McKesson Corporation has reported impressive third-quarter earnings, with a net income of $1.186 billion and EPS of $9.59, surpassing consensus estimates and reflecting an 11.4% year-over-year revenue growth. Following this success, the company has raised its fiscal 2026 adjusted EPS guidance to $38.80 to $39.20. Alongside these financial gains, McKesson is prioritizing its North American operations, having recently concluded the sale of its Norwegian businesses.
“McKesson Corporation · was added to · the Healthcare sector of the CUSP · March 2023”
“McKesson · is one of the stocks most watched by · Zacks.com visitors · lately”
“Shares of McKesson · have returned · +16.6% · over the past month”
“McKesson · is expected to post earnings of · $11.32 per share · for the current quarter”
“McKesson · represents a year-over-year change of · +11.9%”
“McKesson · has a consensus earnings estimate of · $38.85 for the current fiscal year · indicates a year-over-year change of +17.6%”
“McKesson · reported revenues of · $106.16 billion in the last reported quarter · representing a year-over-year change of +11.4%”
“McKesson · beat consensus EPS estimates in · each of the trailing four quarters”
“McKesson · is graded · B · on Zacks Value Style Score”
“McKesson · suggests it may outperform · the broader market · in the near term”
“McKesson Corporation · announced results for the third quarter ended · December 31, 2025 · 2026”
“McKesson · generated cash flow from operations · $1.2 billion · and $1.1 billion of Free Cash Flow”
.jpg&width=160)